Assessing a drug compound by its activity, not simply its structure, is a new approach that could speed the search for COVID-19 therapies and reveal more potential therapies for other diseases.
Click here for original story, Assessing a compound’s activity, not just its structure, could accelerate drug discovery
Source: Phys.org